EP0984008A3 - Nitrosation process - Google Patents

Nitrosation process Download PDF

Info

Publication number
EP0984008A3
EP0984008A3 EP99203614A EP99203614A EP0984008A3 EP 0984008 A3 EP0984008 A3 EP 0984008A3 EP 99203614 A EP99203614 A EP 99203614A EP 99203614 A EP99203614 A EP 99203614A EP 0984008 A3 EP0984008 A3 EP 0984008A3
Authority
EP
European Patent Office
Prior art keywords
formula
compounds
nitrosation process
chem
nitrosation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99203614A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0984008A2 (en
Inventor
Mark Jason Hughes
John Kitteringham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of EP0984008A2 publication Critical patent/EP0984008A2/en
Publication of EP0984008A3 publication Critical patent/EP0984008A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
EP99203614A 1992-02-20 1993-02-11 Nitrosation process Withdrawn EP0984008A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process
GB9203688 1992-02-20
EP93903271A EP0626961B1 (en) 1992-02-20 1993-02-11 Process for the preparation of cyano-methoxyiminomethyl derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP93903271A Division EP0626961B1 (en) 1992-02-20 1993-02-11 Process for the preparation of cyano-methoxyiminomethyl derivatives

Publications (2)

Publication Number Publication Date
EP0984008A2 EP0984008A2 (en) 2000-03-08
EP0984008A3 true EP0984008A3 (en) 2000-05-03

Family

ID=10710781

Family Applications (2)

Application Number Title Priority Date Filing Date
EP99203614A Withdrawn EP0984008A3 (en) 1992-02-20 1993-02-11 Nitrosation process
EP93903271A Expired - Lifetime EP0626961B1 (en) 1992-02-20 1993-02-11 Process for the preparation of cyano-methoxyiminomethyl derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP93903271A Expired - Lifetime EP0626961B1 (en) 1992-02-20 1993-02-11 Process for the preparation of cyano-methoxyiminomethyl derivatives

Country Status (18)

Country Link
US (2) US5545740A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP0984008A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3288704B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100261530B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE194341T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU669355B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2131019C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69328962T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0626961T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2147749T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9203688D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3034295T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9300875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ246940A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT626961E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW224466B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1993017018A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA931132B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
WO1998046226A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Method for treating schizophrenia
AU6966998A (en) * 1997-04-11 1998-11-11 Eli Lilly And Company Composition for treating pain
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0392803A1 (en) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Novel compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0392803A1 (en) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Novel compounds

Also Published As

Publication number Publication date
AU3460793A (en) 1993-09-13
JP3288704B2 (ja) 2002-06-04
GB9203688D0 (en) 1992-04-08
DK0626961T3 (da) 2000-11-06
ATE194341T1 (de) 2000-07-15
ZA931132B (en) 1993-10-14
GR3034295T3 (en) 2000-12-29
WO1993017018A1 (en) 1993-09-02
EP0626961B1 (en) 2000-07-05
NZ246940A (en) 1996-06-25
US6596869B2 (en) 2003-07-22
TW224466B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-06-01
EP0984008A2 (en) 2000-03-08
DE69328962D1 (de) 2000-08-10
CA2131019C (en) 2002-12-24
EP0626961A1 (en) 1994-12-07
CA2131019A1 (en) 1993-08-21
DE69328962T2 (de) 2000-12-28
PT626961E (pt) 2000-10-31
US20020143185A1 (en) 2002-10-03
AU669355B2 (en) 1996-06-06
ES2147749T3 (es) 2000-10-01
US5545740A (en) 1996-08-13
KR100261530B1 (ko) 2000-08-01
MX9300875A (es) 1993-08-31
KR950700292A (ko) 1995-01-16
JPH07504180A (ja) 1995-05-11
HK1012366A1 (en) 1999-07-30

Similar Documents

Publication Publication Date Title
EP0984008A3 (en) Nitrosation process
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
EP0742209A3 (en) Process for the preparation of an optically active quinoline demevalonolacton and process for the preparation of a salt of an optically active quinoline demevalolon
TW223645B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU3707393A (en) Anticonvulsant fructopyranose cyclic sulfites and sulfates
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
HUT64317A (en) Process for production baccatine-iii derivatives and pharmaceutical preparations having these compounds as effective substance
EP0638575A3 (de) Verfahren zur Herstellung von Diorganodialkoxysilanen.
AU609922B2 (en) Substituted 6-phenyldihydro-3(2h)-pyridazinones, a process for their preparation and pharmaceutical preparations containing these compounds
ZA932359B (en) 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them
EP0521393A3 (en) Diclofenac salt, a method for the preparation thereof and pharmaceutical compositions containing it
EP0911415A3 (en) Microbiological manufacture of L-ascorbic acid
CA2137889A1 (fr) Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2202892A (en) Ammonium salt of methyl 4,4,4-trifluoro-3-oxo-butanethioate
EP0590681A3 (en) A process for the preparation of aminothiadiazolylacetyl halide derivatives
CA2193310A1 (fr) Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui les contiennent
PT78636B (en) Process for the preparation esters of 2-bromo-4-methylimidazole-5-carboxylic acid
EP0990646A4 (en) PROCESS FOR THE PREPARATION OF 3- (7-AMIDINO-2-NAPHTHYL) -2-PHENYLPROPIONIC ACID DERIVATIVES
TW265342B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB8707200D0 (en) Chemical process
AU6860794A (en) (Thia)cycloalkyl(b)indoles, process for preparing them and pharmaceutical compositions containing them
AU6530796A (en) Process for producing carbamoylmethylurea derivatives
AU4382989A (en) Thienopyridine type mevalonolactones

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991102

AC Divisional application: reference to earlier application

Ref document number: 626961

Country of ref document: EP

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 453/02 A

AKX Designation fees paid

Free format text: AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SMITHKLINE BEECHAM PLC

17Q First examination report despatched

Effective date: 20020930

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041026

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1025564

Country of ref document: HK